ICER publishes special report on Eliquis and Xarelto submitted to CMS as part of public comment process on Medicare drug price negotiations

2 October 2023 - Report tailored to reflect legislative specifications in the Inflation Reduction Act and subsequent CMS guidance regarding ...

Read more →

Congress’ misguided plan to ban QALYs

8 June 2023 - Paying for health care is a challenge for many Americans, but the House of Representatives is on ...

Read more →

Throwing the baby out with the bath water: Congress considers banning the QALY

3 April 2023 - In late March, the House Committee on Energy and Commerce advanced H.R. 485 - Protecting Health ...

Read more →

A new way to contain unaffordable medication costs - exercising the Government’s existing rights

9 February 2022 - Existing laws could be used to help make many drugs more affordable.  ...

Read more →

Drug prices by committee: one way Biden could lower costs

11 February 2021 - Many countries use independent review boards to balance innovation and profit. ...

Read more →

Biden looks to Germany for answers on how to tackle high U.S. drug prices

20 October 2020 - With the U.S. election just two weeks away, Democratic presidential nominee Joe Biden is offering clues ...

Read more →

ICER methods could be illegal in US, claims US think tank

11 February 2020 - The method used by the US Institute for Clinical and Economic Review (ICER) to gauge whether ...

Read more →